In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8<sup>+</sup> T cell fate decisions.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33636132.
- Also identified by DOI 10.1016/j.cell.2021.02.021 and PMC identifier 8101447.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
How early events in effector T cell (T<sub>EFF</sub>) subsets tune memory T cell (T<sub>MEM</sub>) responses remains incompletely understood. Here, we systematically investigated metabolic factors in fate determination of T<sub>EFF</sub> and T<sub>MEM</sub> cells using in vivo pooled CRISPR screening, focusing on negative regulators of T<sub>MEM</sub> responses. We found that amino acid transporters Slc7a1 and Slc38a2 dampened the magnitude of T<sub>MEM</sub> differentiation, in part through modulating mTORC1 signaling. By integrating genetic and systems approaches, we identified cellular and metabolic heterogeneity among T<sub>EFF</sub> cells, with terminal effector differentiation associated with establishment of metabolic quiescence and exit from the cell cycle. Importantly, Pofut1 (protein-O-fucosyltransferase-1) linked GDP-fucose availability to downstream Notch-Rbpj signaling, and perturbation of this nutrient signaling axis blocked terminal effector differentiation but drove context-dependent T<sub>EFF</sub> proliferation and T<sub>MEM</sub> development. Our study establishes that nutrient uptake and signaling are key determinants of T cell fate and shape the quantity and quality of T<sub>MEM</sub> responses.
Medical subject headings
- Amino Acids
- CD8-Positive T-Lymphocytes
- Immunologic Memory
- Signal Transduction